KRT18 and COVID-19: Importantly, the in vivo functionality of RBD+alum+U-Omp19 vaccine elicited immune responses was evaluated in a severe disease COVID-19 murine model showing that this vaccine was able to confer protection in lungs and brains from i.n. SARS-CoV-2 challenged K18-hACE2 mice.